(Q34282712)

1 August 2017

1 reference

title

The preclinical biology of a new potent and selective progestin: trimegestone (English)

1 reference

1 August 2017

Richard C Winneker

1

1 reference

1 August 2017

Daniel Bitran

series ordinal

2

1 reference

1 August 2017

Zhiming Zhang

series ordinal

3

1 reference

1 August 2017

publication date

1 November 2003

1 reference

1 August 2017

1 reference

1 August 2017

volume

68

1 reference

1 August 2017

issue

10-13

1 reference

1 August 2017

page(s)

915-920

1 reference

Use of hormone replacement therapy by postmenopausal women in the United States

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Progestogens in hormonal replacement therapy: new molecules, risks, and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

In vitro characterization of trimegestone: a new potent and selective progestin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

The pharmacological profile of a novel norpregnance progestin (trimegestone).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900142-9

7 January 2021

10.1016/S0039-128X(03)00142-9

Identifiers

DOI

1 reference

1 August 2017

1 reference